Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1211558.RAnnC1wImmULZwQkCvJx9DuXfHYS6KZb0huewvwdCQ22Q130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1211558.RAnnC1wImmULZwQkCvJx9DuXfHYS6KZb0huewvwdCQ22Q130_assertion type Assertion NP1211558.RAnnC1wImmULZwQkCvJx9DuXfHYS6KZb0huewvwdCQ22Q130_head.
- NP1211558.RAnnC1wImmULZwQkCvJx9DuXfHYS6KZb0huewvwdCQ22Q130_assertion description "[Lastly, we validate the effectiveness of ALX as a chemotherapeutic agent in vivo by demonstrating its ability to cause a significant reduction in tumour cell growth, irrespective of TP53 status, using a mouse leukaemia xenograft model.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1211558.RAnnC1wImmULZwQkCvJx9DuXfHYS6KZb0huewvwdCQ22Q130_provenance.
- NP1211558.RAnnC1wImmULZwQkCvJx9DuXfHYS6KZb0huewvwdCQ22Q130_assertion evidence source_evidence_literature NP1211558.RAnnC1wImmULZwQkCvJx9DuXfHYS6KZb0huewvwdCQ22Q130_provenance.
- NP1211558.RAnnC1wImmULZwQkCvJx9DuXfHYS6KZb0huewvwdCQ22Q130_assertion SIO_000772 25132271 NP1211558.RAnnC1wImmULZwQkCvJx9DuXfHYS6KZb0huewvwdCQ22Q130_provenance.
- NP1211558.RAnnC1wImmULZwQkCvJx9DuXfHYS6KZb0huewvwdCQ22Q130_assertion wasDerivedFrom befree-2016 NP1211558.RAnnC1wImmULZwQkCvJx9DuXfHYS6KZb0huewvwdCQ22Q130_provenance.
- NP1211558.RAnnC1wImmULZwQkCvJx9DuXfHYS6KZb0huewvwdCQ22Q130_assertion wasGeneratedBy ECO_0000203 NP1211558.RAnnC1wImmULZwQkCvJx9DuXfHYS6KZb0huewvwdCQ22Q130_provenance.